Seiji Fukumoto Selected Research

Renal Dialysis (Hemodialysis)

1/2020

Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Fukumoto Research Topics

Disease

36	Hypophosphatemia 02/2024 - 07/2002
33	Osteomalacia 05/2024 - 07/2002
30	Neoplasms (Cancer) 01/2023 - 05/2002
21	Oncogenic osteomalacia 12/2023 - 07/2002
20	Rickets (Rachitis) 05/2024 - 07/2002
17	Hypophosphatemic Rickets 01/2022 - 07/2002
13	Hyperphosphatemia 11/2023 - 07/2005
13	Hypocalcemia 11/2023 - 06/2002
13	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2022 - 07/2003
12	Osteoporosis 03/2024 - 12/2002
12	Hypoparathyroidism 11/2023 - 06/2002
10	Secondary Hyperparathyroidism 06/2017 - 08/2004
8	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2023 - 07/2003
8	Hypercalcemia (Milk Alkali Syndrome) 09/2020 - 05/2002
7	Bone Resorption 01/2017 - 12/2002
6	Hypercalciuria 02/2024 - 05/2002
6	Hyperparathyroidism 01/2022 - 02/2002
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 12/2007
5	Autosomal Dominant Hypophosphatemic Rickets 11/2019 - 07/2002
4	Familial Hyperphosphatemic Tumoral Calcinosis 01/2021 - 10/2009
4	Calcinosis 01/2020 - 10/2005
3	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2016
3	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2003
3	Pseudohypoparathyroidism 11/2023 - 08/2007
3	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 11/2023 - 10/2009
3	Pain (Aches) 01/2023 - 05/2016
3	Primary Hyperparathyroidism 09/2020 - 05/2002
3	Chronic Renal Insufficiency 01/2020 - 11/2010
2	Nephrocalcinosis 02/2024 - 06/2004
2	Rare Diseases (Rare Disease) 11/2023 - 01/2022
2	Alopecia (Baldness) 11/2023 - 06/2017
2	Disease Progression 01/2022 - 05/2002
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 01/2010
2	Hyperostosis-hyperphosphatemia syndrome 01/2021 - 02/2007
2	Atherosclerosis 01/2020 - 04/2016
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2017 - 03/2013
2	Acromegaly 09/2017 - 06/2007
2	Vitamin D Deficiency 01/2017 - 01/2017
2	Neoplasm Metastasis (Metastasis) 05/2016 - 04/2003
2	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 07/2012 - 07/2012
2	type 1 familial Hypocalciuric hypercalcemia 12/2002 - 02/2002
1	Osteoporotic Fractures 02/2024
1	Myalgia 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2022

Drug/Important Bio-Agent (IBA)

45	Phosphates (Orthophosphate)IBA 02/2024 - 07/2002
44	Fibroblast Growth Factor-23IBA 12/2023 - 07/2002
19	1,25-dihydroxyvitamin DIBA 01/2023 - 05/2002
16	Parathyroid Hormone (Parathormone)IBA 02/2024 - 08/2002
13	MineralsIBA 03/2024 - 08/2004
13	CalciumIBA 02/2024 - 05/2002
13	Vitamin D FDA LinkGeneric 01/2023 - 02/2003
12	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021 - 02/2004
9	Calcium-Sensing ReceptorsIBA 02/2024 - 02/2002
8	hydroxide ionIBA 01/2023 - 03/2004
7	Hormones (Hormone)IBA 02/2024 - 08/2007
6	burosumabIBA 05/2024 - 01/2020
5	Saccharated Ferric Oxide (Venofer)FDA Link 11/2023 - 10/2009
5	Proteins (Proteins, Gene)FDA Link 06/2017 - 08/2002
4	Calcitriol (Calcijex)FDA LinkGeneric 10/2017 - 01/2005
4	Diphosphonates (Bisphosphonates)IBA 01/2017 - 05/2002
3	IronIBA 11/2023 - 07/2015
3	Cholecalciferol (Vitamin D3)FDA Link 11/2015 - 02/2003
3	AntibodiesIBA 08/2014 - 11/2009
3	EnzymesIBA 03/2012 - 03/2004
2	GlucocorticoidsIBA 03/2024 - 01/2010
2	AndrogensIBA 03/2024 - 01/2016
2	JTT 305IBA 02/2024 - 11/2015
2	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2023 - 06/2017
2	SaltsIBA 01/2023 - 01/2018
2	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 12/2022 - 01/2022
2	Interleukin-11 (Interleukin 11)IBA 11/2022 - 12/2002
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2016
2	Growth Hormone (Somatotropin)IBA 09/2017 - 03/2013
2	Octreotide (Sandostatin)FDA LinkGeneric 09/2017 - 06/2014
2	25-hydroxyvitamin DIBA 01/2017 - 01/2017
2	AcidsIBA 01/2017 - 06/2004
2	Denosumab FDA Link 01/2017 - 05/2016
2	alfacalcidolIBA 10/2014 - 01/2014
2	ImmunosorbentsIBA 03/2012 - 06/2007
2	calcium phosphateIBA 12/2007 - 06/2007
2	MagnesiumIBA 08/2007 - 06/2002
1	SteroidsIBA 03/2024
1	NucleotidesIBA 02/2024
1	Aquaporin 2IBA 02/2024
1	Vasopressins (Vasopressin)IBA 02/2024
1	Estrogen ReceptorsIBA 02/2024
1	Aromatase InhibitorsIBA 02/2024
1	ferric carboxymaltoseIBA 11/2023
1	ferric derisomaltoseIBA 11/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Dehydroepiandrosterone SulfateIBA 01/2022

Therapy/Procedure

14	Therapeutics 03/2024 - 01/2005
3	Intravenous Administration 11/2023 - 10/2009
3	Kidney Transplantation 07/2012 - 08/2011
3	Transplantation 10/2011 - 09/2007
2	Thyroidectomy 06/2007 - 09/2005
1	Oral Administration 11/2023
1	Intravenous Infusions 12/2021